Influence of GSTT1, GSTM1 and GSTP1 Polymorphisms on the Development of Breast Cancer


Introduction: Every year, more than 10 million women are diagnosed worldwide with breast cancer. Breast cancer remains the leading cause of death from malignancy in women. In Mexico about 12 Mexican women die every day from this disease. Glutathione S-transferase (GST) family consists of a group of isoenzymes involved in Phase II detoxification of xenobiotics by glutathione conjugation. There have been reports showing GST polymorphisms as a risk factor for developing cancer. Objective: Determine if the frequencies of polymorphisms of GSTT1, GSTM1 and GSTP1 are associated with breast cancer development. Materials and Methods: We studied 22 women with breast cancer and a control group of 30 women. DNA was extracted from blood. Polymorphisms of T1 and M1 were identified by multiplex PCR. The identification of GSTP1b (exon 5) and GSTP1c (exon 6), was performed separately by RFLP-PCR, using BsmAI and AciI enzymes respectively. Results: Frequencies of polymorphisms were as follows: for breast cancer group 33% null GSTT1 vs 40% null in the control, 32% null GSTM1 vs 63% of control; 63% heterozygote GSTP1b P1a/P1b and 18% homozygote P1b/P1b, vs 53% heterozygote and 20% homozygote in the control, 41% heterozygote P1a/P1c GSTP1c and 0% homozygote vs 10% heterozygote P1c/P1c and 0% homozygote control. Significant differences were found between GSTM1 and GSTP1c polymorphisms with GSTM1 null percentage higher in the control group and a higher frequency of P1c heterozygotes in the cancer group. Conclusion: As this is a pilot study where the results showed no association with breast cancer, further investigation is required on the involvement of GST genes in neoplasm development.

Share and Cite:

Rodríguez, M. , Mejia, F. , Lecourtois, M. , Domínguez, V. and Castillo, J. (2014) Influence of GSTT1, GSTM1 and GSTP1 Polymorphisms on the Development of Breast Cancer. Journal of Cancer Therapy, 5, 552-559. doi: 10.4236/jct.2014.56063.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Menendez, P., Villarejo, P., Padilla, D., et al. (2012) Epigenetica y cancer colorrectal. Cirugia Espanola, 90, 277-283.
[2] Meza, J., Montano, L.A. and Aguayo, G.A. (2006) Bases moleculares del cancer. Revista de Investigacion Clinica, 58, 56-70.
[3] Romero, F.M., Arreygue, L.S., Hernandez, P.O., et al. (2008) Frecuencia de factores de riesgo de cancer de mama. Ginecologia y Obstetricia de Mexico, 76, 557-572.
[4] Mohar, A., Bargallo, E., Ramirez, M.T., et al. (2009) Recursos disponibles para el tratamiento del cancer de mama en Mexico. Salud Publica de Mexico, 51, 263-269.
[5] Marie, K.F. (2009) Cancer de mama en Mexico: Una prioridad apremiante. Salud Publica de Mexico, 52, 335-230.
[6] Brockmoller, J. (1996) Combined Analysis of Inhereted Polymorphisms in Arylamine N-Acetyl transferase-2, Glutatione S-Transferases M1 and T1, Microsomal Epoxidehydrolase and Cytochrome 450 Enzymes as Modulators of Bladder Cancer Risk. Cancer Research, 56, 3915-3925.
[7] Pavanello, S. and Clonfero, E. (2000) Indicatori biologici di rischio genotossico e polimorfismi metabolici. Medicina del Lavoro, 91, 431-469.
[8] Castillo, C.J., Contreras, S.C., Poblano, R.B., et al. (2007) Actividad en la enzima Glutation S-transferasa T1 en floricultores expuestos a plaguicidas. Bioquimia, 32, 138.
[9] Guo, X., Zeng, Y., Deng, H., et al. (2010) Genetic Polymorphisms of CYP2E1, GSTP1, NQO1 and MPO and the Risk of Nasopharyngeal Carcinoma in a Human. Chinese Population of Southern China. Biomedical Central Research Notes, 3, 212-321.
[10] Kiran, B., Karkucak, M., Ozan, H., et al. (2010) GST (GSTM1, GSTT1 and GSTP1) Polymorphisms in the Genetic Susceptibility of Turkish Patients to Cervical Cancer. Journal Gynecologic Oncology, 21, 169-173.
[11] Hayes, J.D., Fanagan, J.U. and Jowsey, I.R. (2005) Glutathione Transferases. Annual Review of Pharmacology and Toxicology, 45, 51-88.
[12] Sailaja, K., Surekha, D., Nageswara, D.R., et al. (2010) Association of the GSTP1 Gene (Ile105Val) Polymorphism with Chronic Myeloid Leukemia. Asian Pacific Organization for Cancer Prevention, 11, 461-464.
[13] Bolt, H.M. and Their, R. (2006) Relevance of the Deletion Polymorphisms of the Glutathione S-Transferases GSTT1 and GSTM1 in Pharmacology and Toxicology. Current Drug Metabolism, 7, 613-628.
[14] Ruzzo, A., Graziano, F., Loupakis, F., et al. (2007) Perfil farmacogenetico en los pacientes con cancer colon-rectal avanzado tratados con quimioterapia FOLFOX-4 de primera linea. Journal of Clinical Oncology, 25, 1247-1254.
[15] Oliveira, A.L., Rodriguez, F.O., Santos, R.E., et al. (2010) GSTT1, GSTM1, and GSTP1 Polymorphisms and Chemotherapy Response in Locally Advanced Breast Cancer. Genetics and Molecular Research, 9, 1045-1053.
[16] Laffon, B.L., Perez, C.B. and Mendez, F.J. (2004) Influencia de determinados polimorfismos de enzimas metabolicas en la genotoxicidad del estireno. Premio Alca Lliber de la Real Academia Nacional de Farmacia, 70, 95-123.
[17] Parl, F.F. (2005) Glutathione S-Transferase Genotypes and Cancer Risk. Cancer Letters, 221, 123-129.
[18] Ali-Osman, F., Akande, O., Antoun, G., Mao, J.X. and Buolamwini, J. (1997) Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-Length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants. The Journal of Biological Chemistry, 272, 10004-10012.
[19] Eaton, D. and Bammler, T. (1999) Concise Review of the Glutatione S-Transferases and Their Significance to Toxicology. Toxicological Sciences, 49, 156-164.
[20] Young, W.A., Young, H.O., Grady, J., Salama, S.A. and Heo, M.Y. (2001) Usefulness of Genetic Susceptibility and Biomarkers for Evaluation of Environmental Health Risk. Environmental and Molecular Mutagenesis, 37, 215-225.
[21] Custodio, A.C., Almeida, L.O., Pinto, G.R., et al. (2010) GSTP1 Ile105Val Polymorphism in Astro- cytomas and Glioblastomas. Genetics and Molecular Research, 9, 2328-2334.
[22] Holley, S.L., Fryer, A.A., Haycock, J.W., et al. (2007) Differential Effects of Glutathione S-Transferase Pi (GSTP1) Haplotypes on Cell Proliferation and Apoptosis. Carcinogenesis, 28, 2268-2273.
[23] Peklak-Scott, C., Smitherman, P.K., Morrow, C.S. and Townsend, A.J. (2008) Role of Glutathione S-Transferase P1-1 in the Cellular Detoxification of Cisplatin. Molecular Cancer Therapeutics, 7, 3247-3255.
[24] Matheson, M.C., Stevenson, T., Akbarzadeh, S. and Propert, D.N. (2002) GSTT1 Null Genotype Increases Risk of Premenopausal Breast Cancer. Cancer Letters, 181, 73-79.
[25] Garcia, A.D., Rubio, A.R., Cima, M.L., et al. (2007) Metabolic Gene Polymorphisms and Lung Cancer Risk. Mapfre Medicina, 18, 292-304.
[26] Wilson, M.H., Grant, P.J., Hardie, L.J. and Wild, C.P. (2000) Glutathione S-Transferase M1 Null Genotype Is Associated with a Decreased Risk of Myocardial Infarction. The Federation of American Societies for Experimental Biology Journal, 14, 791-796.
[27] Abdel-Rahman, S.Z., El-Zein, R.A., Anwar, W.A. and Au, W.W. (1996) A Multiplex PCR Procedure for Polymorphic Analisis of GSTM1 and GSTT1 Genes in Population Studies. Cancer Letters, 107, 229-233.
[28] Mejia-Sanchez, F., Cadena-Castilo, J. and Sanchez-Meza, J.C. (2013) Development and Application in Mexican of a Method for the Identification of Polymorphisms of GSTP1. Journal of Medicine and Medical Sciences, 4, 287-290.
[29] Leite, J.L., Morari, C.E., Granja, F., et al. (2007) Influence of the Glutathione S-Transferase Gene Polymorphisms on the Susceptibility to Basal Cell Skin Carcinoma. Revista Medica de Chile, 135, 301-306.
[30] Maugard, M.C., Charrier, J., Pitard, A., et al. (2001) Genetic Polymorphism at the Glutathione S-Tranferase (GST) P1 Locus Is a Breast Cancer Risk Modifier. International Journal of Cancer, 91, 334-339.<::AID-IJC1057>3.0.CO;2-H
[31] Millikan, R., Pittman, G., Tse, C.K., et al. (2000) Glutathione S-Transferases M1, T1, and P1 and Breast Cancer. Cancer Epidemiology Biomarkers Prevention, 9, 567-573.
[32] Zhao, B. (2001) Dietary Isothiocyanates, Glutathione S-Transferase -M1, -T1 Polymorphisms and Lung Cancer Risk among Chinese Women in Singapore. Cancer Epidemiology, Biomarkers & Prevention, 10, 1063-1067.
[33] Zheng, T., Holford, T. R., Zahm, S. H., et al. (2003) Glutathione S-Transferase M1 and T1 Genetic Polymorphisms, Alcohol Consumption and Breast Cancer Risk. British Journal of Cancer, 88, 58-62.
[34] Garcia-Closas, M., Kelsey, T.K., Hankinson, E.S., et al. (1999) Glutathione S-Transferase Mu and Theta Polymorphisms and Breast Cancer Susceptibility. Journal of the National Cancer Institute, 91, 1960-1964.
[35] Vogl, D.F., Taioli, E., Maugard, C., et al. (2004) Glutathione S-Transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis. Cancer Epidemiology, Biomarkers & Prevention, 13, 1473-1479.
[36] Hashemi, M., Eskandari-Nasab, E., Fazaeli, A., et al. (2012) Association between Polymorphisms of Glutathione S- Transferase Genes (GSTM1, GSTP1 and GSTT1) and Breast Cancer Risk in a Sample Iranian Population. Biomarkers in Medicine, 6, 797-803.
[37] Sohail, A., Kanwal, N., Ali, M., et al. (2013) Effects of Glutathione-S-Transferase Polymorphisms on the Risk of Breast Cancer: A Population-Based Case-Control Study in Pakistan. Environmental Toxicology and Pharmacology, 35, 143-153.
[38] Lu, S., Wang, Z., Cui, D., Liu, H. and Hao, X.S. (2011) Glutathione S-Transferase P1 Ile105Val Polymorphism and Breast Cancer Risk: A Meta-Analysis Involving 34,658 Subjects. Breast Cancer Research and Treatment, 125, 253- 259.

Copyright © 2022 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.